Alpha Teknova, Inc. (TKNO)
- Previous Close
1.7200 - Open
1.7100 - Bid 1.2400 x 200
- Ask 1.7100 x 100
- Day's Range
1.6800 - 1.7550 - 52 Week Range
1.6200 - 4.2700 - Volume
11,895 - Avg. Volume
12,567 - Market Cap (intraday)
68.583M - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-1.1600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.50
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
www.teknova.com210
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: TKNO
Performance Overview: TKNO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TKNO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TKNO
Valuation Measures
Market Cap
69.40M
Enterprise Value
71.37M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.47
Price/Book (mrq)
0.77
Enterprise Value/Revenue
1.95
Enterprise Value/EBITDA
-2.79
Financial Highlights
Profitability and Income Statement
Profit Margin
-100.26%
Return on Assets (ttm)
-13.89%
Return on Equity (ttm)
-38.73%
Revenue (ttm)
36.68M
Net Income Avi to Common (ttm)
-36.78M
Diluted EPS (ttm)
-1.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
28.48M
Total Debt/Equity (mrq)
33.83%
Levered Free Cash Flow (ttm)
-17.51M